A B S T R A C T The formation of tissue iodoproteins during the peripheral metabolism of the thyroid hormones was examined by determining the concentration of nonethanol-extractable 'I (NEWI) in various tissues after the intravenous injection of 3,5,3'-triiodo-L-thyronine (T3-2"I) and L-thyroxine-I (T4-'I) in groups of rats with iodide-blocked thyroid glands. 3 days after T3-'I and 7 days after T4-'I injection the concentration of NESI in the liver and kidney was 5-10 times greater than in plasma. Smaller but nonetheless significant concentrations of NEST were demonstrated in skeletal and cardiac muscle. Hepatic subcellular fractionation studies revealed that the major portion of the liver NE'I was in the microsomal fraction. Lower concentrations of NEST were present in the nuclear, mitochondrial, and soluble fractions. When similar studies were performed in groups of rats pretreated with phenobarbital, an increase in the metabolic clearance of T3-'I (30%) and T4-'I (100%) was observed along with a highly significant increase in the NESI concentration of the liver and plasma. The increase in hepatic NESI in these studies was primarily due to the microsomal component.
INTRODUCTION
Recent studies from this laboratory have demonstrated that after injection of 3,5,3'-triiodo-L-thyronine-'I (T3-'I) and L-thyroxine-'I (T4-"I) into human beings and rats, a small but significant portion of the hormonal iodine appears in the plasma in a form which is nonextractable (NEI) in acid butanol (1) . Based on its physicochemical characteristics and its behavior in electrophoretic and chromatographic systems, plasma NESI was identified as iodoprotein. Insignificant amounts of circulating iodoprotein were observed after injection of iodide-'I or monoiodotyrosine-'I (MiSIT). Studies performed in thyroidectomized rats indicated that the plasma iodoproteins originated during the peripheral metabolism of the thyroid hormones and not from thyroidal secretion. In separate studies Brown-Grant (2) has postulated that plasma iodoprotein formation might occur during triiodothyronine metabolism in guinea pigs.
His suggestion was based on a decreasing plasma disappearance rate for injected T3-"1I with a relative increase with time in plasma trichloroacetic acid-precipitable radioactivity.
The transfer of hormonal iodine to circulating proteins during hormonal metabolism raised the possibility that structural and soluble tissue proteins might be iodinated also. Although iodoprotein formation during thyroid hormone metabolism by various tissues in vitro has been frequently reported (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) , the results of some of these studies must be queried since the incubation systems which were employed were supplemented with flavin mononucleotide (FMN). This cofactor in the presence of light has been shown to produce deiodination of iodothyronines and radioactivity remaining at the origin of chromatograms in the absence of any tissue components (13, 14) . Moreover, the addition of a variety of proteins which have no deiodinating capability alone greatly accelerates this FMN effect (15) . In several reports, however, in vitro iodoprotein formation was clearly demonstrated in incubation systems which did not require FMN (8, (9) (10) (11) (12) . Fewer data are available on in vivo iodoprotein formation during thyroid hormone metabolism. In a study of the tissue localization of T4-'31I and T3-I in guinea pigs, Ford, Corey, and Gross (16) prepared radiochromatograms from tissue homogenates obtained 2-3 hr after intravenous injection of the labeled hormones. These authors observed that a small percentage of the tissue total radioactivity remained at the origin in the chromatograms of several tissues and speculated that the origin radioactivity might be a protein or polypeptide. The formation of tissue iodoproteins during hormone metabolism has also been demonstrated by Nunez, Rappaport, Jaquemin, and Roche (17) . More recent studies of Dratman, Kuhlenbeck, and Crutchfield (18) suggest that iodoproteins may result from hormone metabolism in the developing neuraxis of the newborn rat. In a preliminary study from this laboratory, analysis of liver and carcass homogenates from rats whose iodine pools had been equilibrated with 'iI administered by daily injections revealed that approximately 10% of the tissue organic radioiodine was NE'I (1).
Despite these studies, comparatively little attention has been paid to this pathway in the in vivo metabolism of the thyroid hormones. The current study was, therefore, initiated further to explore this problem. An analysis was made of tissue and hepatic subcellular distribution of NEST after T4 and T3 metabolism in normal rats and in animals in which the rate of hepatic hormone metabolism was stimulated by the administration of phenobarbital (19) . The data presented in this report demonstrate that structural and soluble tissue iodoprotein formation occurs as a normal consequence of thyroid hormone metabolism. Moreover, phenobarbital treatment results in an increase in hepatic microsomal and plasma NESI concentrations. Since we have previously reported that phenobarbital treatment leads to an increase in the specific activity of iodothyronine deiodinase in the hepatic microsomal fraction (20) , in vitro studies of NESI formation during the metabolism of T4 and T3 by isolated hepatic microsomes were carried out also.
METHODS
Preparations of L-thyroxine-w'I (T4-'I), L-thyroxine-'I (T4-mI), 3,5,3'-triiodo-L-thyronine-'I (T3-'I), and 3,5,3'-triiodo-L-thyronine-'I (T3-I) with specific activities ranging from 20 to 40 mc/mg were obtained from Abbott Laboratories, North Chicago, Ill. Carrier-free iodide-"1I was obtained from the same source. 3-monoiodotyrosine-"I (M'IT), SA 50 mc/mg, was prepared by the iodination of tyrosine by the procedure outlined by Greenwood, Hunter, and Glover (21) . Radioactivity was measured in a two channel Autogamma Spectrometer (Packard Instruments Co., Series 314E). When both 'iI and 'I were present in the same sample, the counts appearing in the 'I channel were appropriately corrected for the 'I. Sufficient counts were accumulated so that counting error did not exceed 1%o.
Male Sprague-Dawley rats weighing between 150 and 250 g were employed in all studies. They were maintained on Wayne Lab-Blox and were allowed water ad lib. The phenobarbital (PB) groups were prepared by daily intraperitoneal injections of PB, 100 mg/kg body weight, for 5 days preceding the injection of labeled thyroid hormones. Treatment with PB was continued throughout the entire course of the various metabolic studies. Control animals were injected with isotonic saline. All rats were also injected daily with 1 mg NaI starting from the day preceding the administration of labeled thyroid hormones and throughout each study in order to prevent thyroidal accumulation of radioiodine released from the radioactive hormones during metabolism.
The experimental procedures which were carried out for the studies of T4-mI and T3-V'I metabolism were similar.
An exact amount ,c) of the 'I-labeled iodothyronine in 1% albumin was injected intravenously through the tail vein in groups of two to four control and PB-treated rats. Heparinized blood samples were obtained at various intervals by cutting the tail. 35 min before the termination of each experiment 0.15 ,uc of the MI-labeled iodothyronine under study was injected into the tail vein. The rats were killed by exsanguination through the abdominal aorta under light ether anesthesia 3 days after T3-w'I injection and 7 days after T4-5I injection. The liver, kidney, heart, and a portion of skeletal muscle from the lower extremity were rapidly excised, chilled in ice, and weighed. 1 g portions of the liver, kidney, and skeletal muscle were minced and homogenized at 50C in 0.05 M phosphate buffer, pH 5.8. The entire heart was processed similarly after the chambers were opened and small blood clots removed by gentle rinsing in ice-cold saline. The radioactivity in samples of plasma and these tissue homogenates was then determined before and after four extractions with four volumes of 95% ethanol.
An additional 2 g portion from each liver was homogenized at 50C in 0.25 M sucrose and subcellular fractions were prepared by differential centrifugation according to the method of Schneider and Hogeboom (22) . The radioactivity of the nuclear, mitochondrial, microsomal, and supernatant fractions was determined before and after 95% ethanol extraction as described above.
The counting rates in each sample were related to those in exact dilutions of the injected doses of both the '1I-and 3"I-labeled iodothyronines which were counted concurrently in order to obviate corrections for isotopic physical decay.
The degree of extraction of the '3I-labeled iodothyronine in each sample was used as a control for the extraction procedure. Thus, the actual per cent NE"5I in any sample was considered equivalent to the difference between the observed per cent NE'I and the per cent NE1311.
Metabolic clearance of the thyroid hormones was calculated as the product of the fractional disappearance rate of plasma radioactivity over the first 48 hr of each study and the total distribution volume determined by "0" time extrapolation. In the T3-'I turnover studies, however, a major portion of the plasma radioactivity within this time interval consists of iodide-'I and NE1'I. Additional plasma samples were, therefore, counted before and after precipitation with 10%o cold trichloroacetic acid (TCA). The concentration of T3-u'I was assumed to represent the difference between the TCAprecipitable radioactivity and the NEW. formed for T3-'25I and T4-15I metabolism. The data from these studies were pooled and analyzed statistically using Student's t test (23) .
The occurrence of NE'I in skeletal and cardiac muscle was examined further in two additional experiments each using groups of three rats with iodide-blocked thyroid glands. Animals were killed as described above, 3 days after the intravenous injection of 40 sc T3-'2I and 17 hr after the intravenous injection of 0.15 ,uc albumin-"81I (Abbott Laboratories). In one experiment (rat Nos. 787-789) excised skeletal and cardiac muscle was minced and counted before and after seven washes with 3 ml human serum. The muscle minces were then homogenized in 0.05 M phosphate buffer, pH 5.8, and T3-"'I (1000-2000 cpm) was added. The samples were recounted, extracted four times with four volumes of 95% ethanol and again counted with appropriate standards of the injected dose. In another group of animals (rat Nos. 849-851), the excised skeletal and cardiac muscle was homogenized in 10 ml phosphate buffer and centrifuged at 100,000 g for 60 min in a preparative ultracentrifuge (Arden Instruments, Inc., Rockville, Md.). The sedimented particles were suspended in 10 ml of the same buffer and recentrifuged. The particulate fraction was then processed in the same manner as the muscle homogenates described above. In both of these experiments, the loss of albumin-"I counts during the washing procedure or ultracentrifugation was assumed to reflect the degree of removal of plasma which had been trapped within the tissue sample. The degree of extraction of the added T3-P8'I served as a control of the extraction procedure.
The rate of formation of NE'I was studied in relation to the deiodination of T4-'"I and T3-1VI by liver microsomes according to techniques previously described (20) . Briefly, microsomes were harvested from groups of control and phenobarbital-treated rats by differential centrifugation and washed three times in 0.05 M phosphate buffer, pH 5.8.
Incubations were carried out in 2 ml of the same buffer containing 4 mg microsomal protein, tracer T4-'"I or T3-1JI, and various concentrations of nonradioactive T4 or T3 (0.25-10.0 ,ug/ml). After 10 min the reaction was terminated by the addition of 2 ml of human serum. The per cent iodide was determined by rapid paper electrophoresis (24) and the per cent NE1'I by counting a sample of the reaction mixture before and after four extractions with four volumes of 95% ethanol. Appropriate samples were processed in parallel to correct for the iodide-'lI present in the radioactive preparations which were used and for variations in the extraction procedure. For studies of M"'IT deiodination and NE'jI formation, microsomes were prepared as described by Stanbury (25) . Incubations were carried out at Table I .
The highest concentrations of NE125I occurred in the liver and kidney. In the muscle and heart NE"I concentrations were appreciably less than in the plasma. Phenobarbital treatment induced a 30% increase in the metabolic clearance of T3-'=I and was associated with a significant increase (P < 0.001) in the NEI concentration in the liver and plasma. Hepatic NE1"I concentration rose from 37.6 +2.2 x 104 to 52.4 +3.2 X 10-4 per cent of the total dose per gram and the plasma NE1'"I increased from 7.5 +0.5 X 10-4 to 12.8 +0.9 X 10-4 per cent of the dose per milliliter. The increase in the hepatic and plasma NEIZI concentration was due to an increase in both the tissue total '25I and the per cent of the tissue total "S5I which was nonextractable. No significant changes in the NE"25I concentration were observed in kidney, muscle, and heart after phenobarbital treatment. Analysis of plasma samples obtained during these turnover studies revealed that the mean plasma NE'I concentration of the PB-treated group exceeded the mean NE'I concentration of the controls at all time intervals studied ( Fig. 1) despite the fact that the plasma total "I was generally lower in the PB-treated group. When tissue analyses were carried out 7 days after the intravenous injection of T4-'I (Table II) , the relative distribution of NE'I among the various tissues was comparable to that observed in the T3-VI studies. The highest NE'I concentration occurred in the liver and kidney. Phenobarbital treatment resulted in an increase in the mean metabolic clearance of T4-'I from 36.7 ±2.2 to 70.1 ±4.1 ml/day per 200 g body weight (P < 0.001) and in the NE"I concentration of the plasma (P < 0.05) and liver (P < 0.01).
Special studies were performed to determine whether the low concentrations of NE1I observed in muscle and heart after the metabolism of T3-'I and T4-'I resulted from NEI formation within these tissues or from plasma NESI trapped within the tissue sample. Muscle and heart minces were prepared from three rats (Nos. 787-789) 3 days after T3-VI and 17 hr after albumin-"8I injection (Table III) . Based on data from preliminary studies, albumin-'I employed as a label for the plasma proteins (including plasma NEI) was considered to be completely distributed at this time interval. Extensive washing of these tissue minces removed an average of 94.4% of the albumin-"'I from the muscle and 91.0% from the heart. After homogenization of the washed minces followed by extraction, an average of 33.4% and 31.5% of the washed tissue 'I was nonextractable for the muscle and heart, respectively. Thus, an average of 8.5% of the muscle total 'I and 12.7% of the heart total "I was NE'I. The estimated contribution of the relidual plasma NE'S to the tissue NE'S was then cal- culated. The residual plasma NEwI in the tissue after washing was estimated as the product of the plasma NE'I concentration, the plasma space per gram of tissue [(% dose albumin-131I/g tissue)/(% dose albumin-1"I/ml plasma)], and the fraction of albumin-"31I remaining in the tissue after washing. These calculations showed that residual plasma NE'"I contributed only 2.6 and 4.4% to the observed NE1'6I in the muscle and heart, respectively. Another study was designed to remove the plasma NE'I from the muscle and heart more effectively and to determine whether the NE'I in these tissues occurred in the particulate fractions (Table III, rat Nos. 849-851). Homogenates of muscle and heart were obtained from animals injected with T3-1"I and albumin-31I according to the procedure described above. After washing and extraction of the particulate fractions of these tissue homogenates an average of 18.5 and 15.1% of the initial muscle and heart "I was nonextractable.
The calculated contribution of residual plasma NE1"I to the tissue NE1"I in these studies was less than 1%.
Hepatic subceigular distribution of NE155I. The NE'I concentration was determined in subcellular fractions prepared from portions of the livers obtained from the same animals described in Tables I and II. Table   IV shows the concentration of NEwI in the various hepatic subcellular fractions 3 days after the injection of T3-16I. The highest concentration of NE'I occurred in the microsomal fraction. The NE'I which was observed in the nuclei and mitochondria was not corrected for cross-contamination of these fractions by other organelles. In the PB-treated group, there was a significant increase in the NE"I concentration in the microsomes (P < 0.001) and in the supernatant fraction (P <'0.01). The hepatic subcellular NE'I concentrations after T4-'"I metabolism are shown in Table V .
The NE'I distribution was similar to that obtained after T3-'I metabolism. Phenobarbital treatment resulted in a marked increase in the microsomal NE'I concentration. The small increase in the supernatant fraction was not significant statistically.
In vitro studies. The enzymatic nature of the deiodination of T4 and T3 by hepatic microsomes (12, 27, 28) and the increased rate of deiodination by microsomes from PB-treated rats have been demonstrated previously (20) . Fig. 2 demonstrates that a linear relationship was obtained between the reciprocal of the substrate concentration and the reciprocal of the velocity of both iodide formation and NEI formation. Moreover, the rate of formation of NEI and iodide (I-) was increased when microsomes from PB-treated rats were used. Table VI lists the Vmas for iodide and NEI formation for three experiments using T4 as substrate and two studies using T3 as substrate. The increase in Vm.. for both reaction products is evident for the PB-treated microsomes. When MiZIT was incubated with microsomes Data are pooled from three separate experiments. NS = not significant (P >0.05).
from control and PB-treated rats no NE=T was formed although substantial deiodination rates for this compound were clearly demonstrated (11.7-57.0% deiodination per 10 min in 16 separate incubation flasks). Similarly, no NEST was formed when microsomes were incubated with 'I-. A difference in the hepatic microsomal metabolism of T4 and T3 was observed during all incubation studies. Relative to deiodination, more NEI was formed during T3 metabolism than during T4 metabolism. The mean ratio (VmazNEI/VmaxTI) for the T3 studies was 0.54 ±0.04 which was significantly greater (P < 0.01) than that observed in the T4 studies 0.30 ±0.04 (Table   VI) .
DISCUSSION
The present study has demonstrated clearly that NEI occurs in the peripheral tissues as well as in the plasma during the metabolism of the thyroid hormones. Although no chemical characterization of the tissue NEI has been carried out at this time, the nonextractability of hormonal iodine in 95% ethanol suggests that NEI represents iodoproteins. The highest concentrations of NEI after T3 and T4 metabolism occurred in the liver and kidney. Smaller but nonetheless significant concentra- The liver fractionation studies indicate that the hepatic NEI is associated with all of the separated subcellular organelles and the soluble fraction. Since the major portion of the hepatic NEI occurred in the microsomal fraction, the NEI which was observed in the nuclear and mitochondrial fractions might be due to the variable contamination of these fractions by microsomes which generally occurs when the current method of differential centrifugation is employed. Further studies utilizing methods which result in highly purified nuclear and mitochondrial fractions and which assess the degree of microsomal contamination of these fractions will be required to determine if NEI does, in fact, occur in the nuclei and mitochondria. The relationship between the hepatic soluble NEI and the circulating iodoproteins demonstrated during thyroid hormone metabolism in this study and previously (1) remains to be elucidated.
A close relationship between the rate of NEI formation and thyroid hormone metabolism in the intact animal is indicated by the increase in NEI concentration in liver and plasma when the rate of hepatic hormone Tissue Iodoprotein Formation during Thyroid Hormone Metabolism metabolism was increased by pretreatment with phenobarbital. Liver fractionation revealed that the increase in hepatic NEI was due primarily to a marked increase in the microsomal fraction. The localization of hepatic NEI to the microsomal fraction and its increase after PB treatment are of special interest. First, subcellular fractionation studies have shown that the microsomal fraction binds a large portion of hepatic T4 after equilibration between liver and plasma has occurred (30) . Second, the increase in hepatocellular T4-binding in rats after PB treatment (31) has been attributed solely to an increase in hepatic microsomal binding (30) . Third, in vitro studies of iodothyronine metabolism by liver microsomes have demonstrated an increase in the specific activity of iodothyronine deiodinase in microsomes harvested from PB-treated rats (20) . Finally, the plasma NEI, tentatively identified as iodoalbumin (1) , may possibly be synthesized in the hepatic microsomal fraction. The physical proximity of the microsomal sites of iodothyronine metabolism and albumin synthesis and the parallel increases in liver microsomal and plasma NEI in the PB-treated rats thus raise the possibility that iodination of nascent microsomal albumin occurs during the metabolism of the thyroid hormones. Since we have previously estimated that the circulating iodoproteins might be derived entirely from peripheral hormone metabolism (1), it is possible that the elevated plasma iodoprotein concentration in Graves' disease (32, 33) may well result from the increased peripheral metabolism of the thyroid hormones in this condition.
The in vitro incubation studies performed in the current investigation show that the kinetics of NEI formation appear to be similar to those of deiodination of the iodothyronines. Furthermore, the increased rate of deiodination by PB-microsomes was accompanied by a proportional increase in the rate of microsomal NEI formation. Other workers have also reported the association of chromatographic origin radioactivity (presumably NEI) and iodide formation during the metabolism of the iodothyronines by liver homogenates (9, 10, 12) and microsomes (11) . The lack of NEI formation during the metabolism of 3-monoiodotyrosine (MIT) suggests the specificity of this pathway for the iodothyronines. Although the analogy between the in vivo and in vitro studies reported herein is of interest, additional studies must be performed before the in vitro system can be considered a useful model to elucidate the nature of the transfer of hormonal iodine to tissue and plasma proteins. These studies should include a kinetic analysis of the rate of NEI formation in vivo as well as a demonstration of the chemical similarity of the compounds involved.
The commercial preparations of radioactive thyroid hormones used in this investigation were labeled by the iodine exchange reaction which presumably places the radioiodine atom exclusively in the phenolic ring (34) . During studies of thyroxine metabolism in vitro, Plaskett (10) and Wynn and Gibbs (11) reported that the major portion of the phenolic ring iodine is removed as iodide. The primary pathway for the nonphenolic ring iodine and the thyronine skeleton, however, was fixation to the structural tissue proteins. The observations in the current report that phenolic ring iodothyronine iodine becomes fixed to tissue proteins in the intact animal thus suggests that other portions of the iodothyronine molecule might be present also. Preliminary studies of the metabolism in rats of nonphenolic ring iodine-labeled T4 in our laboratory have demonstrated that nonphenolic ring iodothyronine iodine also contributes to plasma and tissue NEI. The potential presence of the carbon thyronine skeleton in these fixed tissue and soluble iodoproteins would be of great interest but must await further investigation.
The available data do not allow any quantitative estimates of the fraction of hormonal iodine which becomes covalently linked to tissue and plasma proteins. Only one arbitrary time interval, after most of the hormone had been metabolized, was examined for each iodothyronine. Moreover, the observed NEI in tissues may represent a number of different iodoproteins each with its own rate of metabolism. The rate of metabolism of plasma NEI, in human subjects, appears similar to that of plasma albumin (1) . The data from isotopically equilibrated rats reported previously (1) suggest that, in the steady state, NEI concentration in tissues and plasma constitutes approximately 10% of the organic iodine. Even if only a small fraction of hormonal iodine becomes linked to structural tissue and soluble proteins, the chemical alteration of these cellular constituents during hormonal metabolism may be of basic physiological importance.
